Among medications commonly prescribed to improve cognitive function, we identified donepezil and galantamine, acetylcholinesterase inhibitors that target ACHE and ACHE/BCHE and brexpiprazole (HTR2A, DRD2, HTR1A), a dopamine receptor partial agonist used for AD-associated agitation. This evidence concerns the gene HTR2A and Alzheimer disease.